Trial
NCT04452097
Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Baylx Inc.
Collaborators
—
Condition
COVID-19
Intervention
Human umbilical cord mesenchymal stem cells + best supportive care
Why stopped
It is a strategic decision by the company, coupled with low incidence of ARDS cases following widespread vaccination efforts.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-29